Sylvie Labrune

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Nasopharyngeal carriage of SARS-CoV-2 among health personnel with symptoms suggestive of COVID-19 in a University Hospital in the Paris suburbs

Nasopharyngeal carriage of SARS-CoV-2 among health personnel with symptoms suggestive of COVID-19 in a University Hospital in the Paris suburbs

Journal: La Revue de medecine interne

Published: May 07, 2020

Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.

Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.

Journal: Journal for immunotherapy of cancer

Published: April 13, 2020

Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.

Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.

Journal: PloS one

Published: December 26, 2018

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab.

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab.

Journal: Journal for immunotherapy of cancer

Published: December 17, 2018

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.

Journal: Oncoimmunology

Published: January 11, 2018

Clinical factors associated with early progression and grade 3-4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab.

Clinical factors associated with early progression and grade 3-4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab.

Journal: PloS one

Published: December 17, 2017

Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer.

Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer.

Journal: Oncoimmunology

Published: November 14, 2017

Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration.

Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration.

Journal: Oncotarget

Published: August 05, 2017

Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges.

Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 29, 2016

Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: report of a case.

Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: report of a case.

Journal: BMC cancer

Published: December 08, 2014

Miliary cerebral carcinomatosis secondary to EGFR mutation-positive lung adenocarcinoma

Miliary cerebral carcinomatosis secondary to EGFR mutation-positive lung adenocarcinoma

Journal: Revue des maladies respiratoires

Published: June 29, 2014

Bilateral pneumothorax complicating cystic metastases of bronchial squamous cell carcinoma under erlotinib.

Bilateral pneumothorax complicating cystic metastases of bronchial squamous cell carcinoma under erlotinib.

Journal: Tumori

Published: June 11, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026